Skip to main content
 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 15, 2025
Expenses
$50,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Antimicrobial resistance; advanced molecular detection; national wastewater surveillance system (SEWER Act, H.R. 766).

Fiscal Year 2026 appropriations for NIH, CDC, NSF, DOE Office of Science, USDA research programs.

Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).

Microbiome research impact on agricultural sciences.

 Bills named in this filing 7
  • H.R. 766
    SEWER Act
  • H.R. 1864
    Risky Research Review Act
  • S. 854
    Risky Research Review Act
  • H.R. 2756
    National Biotechnology Initiative Act of 2025
  • S. 1387
    National Biotechnology Initiative Act of 2025
  • H.R. 2582
    Expanding Partnerships for Innovation and Competitiveness Act
  • S. 1235
    Expanding Partnerships for Innovation and Competitiveness Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem